August 2009 Volume 5, Issue 8
Volume 5, Issue 8 | August 2009
August 2009
In this Issue
Global News
Failed drugs reincarnated
Israel’s Optimata, Teva join forces to develop salvaged cancer drugsBolus of growth
Mylan chooses Bangalore’s Biocon as global generic biologics partnerA flurry of activity
Shifting its focus to neurological conditions, Lundbeck acquires Danish biotech NeuronIcon and U.K.-based drugmaker LifeHealthSurvive to thrive
CombinatoRx, Neuromed to merge in all-stock transactionLet it bleed
CDI reprograms blood cells into stem cells using a small volume of human blood; expands drug testing agreement with RocheGeron to provide stem cells to GE Healthcare
Companies to develop and commercialize cellular assay products derived from human embryonic stem cellsInformatics
Search for pathway-level biomarkers
Agilent Foundation awards grant to UCSD to develop system for analyzing proteomics data and identifying protein-network cancer biomarkersA new home for SQL*LIMS
Seeking new strategic direction, Life Technologies sells laboratory information management software business to LabVantageTGen tapped for ‘biobank’
Luxembourg selects TGen to create biobank for storage of blood and tissue samples for scientistsA ‘crossomics’ collaboration
Genedata AG signs multi-year bioinformatics deal with Roche subsidiary Chugai PharmaceuticalsSwiss success
Medidata makes important deals with two different Swiss pharma companies in a two-week periodResearch & Development
J&J's spending spree continues
Johnson & Johnson buys $1 billion stake in Elan to acquire Alzheimer's programThey’re bonded by blood
Catalyst Biosciences, Wyeth Pharmaceuticals team up to treat hemophilia in collaboration worth up to $500 millionAntibody partnership has eggs-cellent potential
Morphotek partners with Synageva BioPharma to develop therapeutic monoclonal antibodiesProtein partners from opposite sides of the Pacific
California-based Maxygen and Japan-based Astellas form joint venture around protein therapiesA merger of equals in specialty diagnostics
Viracor merges molecular diagnostic testing services with IBT Laboratories’ focus on immunology testing to create specialty diagnostics companyAutomation & Instrumentation
Blood test for Alzheimer's disease likely within 12 to 18 months
Millipore and Proteome Sciences sign licensing agreement to detect the disease in pre-symptomatic stageAn array of advantages
Aushon’s 2470 microarray printer to provide customized solution for small-molecule screening at the Broad Institute.Nanos from the bottom up
Particle Sciences and Microfluidics combine to advance pharmaceutical nanotechnologyAnalytical team-up
RTS Life Science is partnering with Hall Analytical Laboratories to provide analytical services and consultancy in automation, inhaler testingAiming to create the ‘disposable factory’
Sartorius Stedim Biotech partners with SAFC Biosciences to integrate filtration and liquid handling systems with cell culture media manufacturing services.Editor's Focus
Foreign governments feed biotechnology venture capital firms as U.S. appetite for bailouts wanes
While the suggestion that the United States government bail out venture capital firms has failed to attract support from government leaders—and would surely raise taxpayer ire—the mood is quite different overseas, according to recent media reports.Patent News
Senate Committee: 12 years of data exclusivity is cool
The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee voted last month in favor of a proposal by Sens. Kay Hagan (D-N.C.), Michael Enzi (R-WY) and Orrin Hatch (R-UT) to create a follow-on biologics (FOB) pathway that provides 12 years of data exclusivity for brand-name biologic drugs.Commentary
Guest commentary: American pathway to generic biologics approval remains undefined
As we stand at the forefront of major changes across the healthcare industry, a pathway for the approval of generic biologics will be one of the major initiatives in the government’s efforts to achieve reduced costs.Genomics & Proteomics
De novo gene genesis
Researchers identify primate-specific sequences in the human genome in comparative genomics studySticking its feet into the pool
Alnylam joins GSK in donating intellectual property to patent pool for neglected tropical diseasesProtein power
Celera issues licenses for five oncology targets to Bayer Schering PharmaTwo Xs mark diagnostic spot
Exosome Diagnostics and DxS collaborate to develop blood-based tests for key cancer mutationsHigh-value vaccine investment
Juvaris to use Antigen Discovery’s protein microarray screening system to discover disease-specific antigens and fuel its vaccine pipelineNews Briefs
House vote a victory for biotechs in biosimilars battle
A House panel has approved a provision in legislation that would give biosimilar drugs 12 years of protection from competing medicines.
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
The unsung tools behind analytical testing success
Learn how fundamental laboratory tools like pipettes and balances support analytical precision.
Improving ALS research with pluripotent stem cell-derived models
Discover new advancements in modeling amyotrophic lateral sclerosis.
Automating 3D cell selection
Discover precise automated tools for organoid and spheroid handling.
